2,045 active funding opportunities
Funds early stage clinical trials of novel drugs and neuromodulatory devices for psychiatric disorders to assess safety, target engagement, and efficacy.
Supports early stage testing of pharmacologic or device-based interventions for mental disorders using experimental therapeutics and clinical trials.
Funds early career research in hearing, balance, smell, taste, voice, speech, or language to generate preliminary data for R01 applications.
Funds early stage clinical trials testing pharmacologic or device-based interventions for mental disorders with a focus on mechanism evaluation.
Funds clinical trials testing mental health system interventions to improve care delivery, coordination, and outcomes across diverse settings.
Funds clinical trials testing effectiveness of mental health treatment, preventive, and services interventions in community and practice settings.
Supports pilot research developing and testing novel psychosocial interventions for mental disorders with clinical trials required.
Funds pilot studies optimizing mental health interventions and innovative service delivery with clinical trial requirements.
Funds clinical trials testing non-pharmacological and pharmacological interventions for mental disorders, focusing on efficacy and mechanisms of therapeutic change.
Supports pilot research developing and testing novel psychosocial interventions for mental disorders with phased clinical trial support.
Funds vision-related research using secondary data analysis and statistical method development, excluding clinical trials.
Supports cooperative agreements for clinical trials in communication disorders requiring FDA oversight or higher risk to establish effective interventions.
Supports innovative translational research projects that accelerate treatment development and dissemination across diseases.
Supports early-stage development of novel informatics tools to advance cancer research across biology, treatment, detection, and prevention.
Supports development of animal and ex vivo models to improve translational neurotherapeutic discovery for neurological disorders.
Supports studies to demonstrate biological activity of neurotherapeutic agents for neurological disorders, advancing translational research.
Supports assay development and screening to identify neurotherapeutic agents for neurological and neuromuscular disorders.
Supports planning clinical trials to improve cancer prevention, screening, treatment symptom management, and survivorship outcomes.
Funds small scale biomedical research and minimal risk clinical trials at underfunded health professional and graduate schools.
Supports planning grants to improve design and feasibility of cancer prevention and control clinical trials.
Supports multidisciplinary research programs to develop new drugs and neurostimulation devices for mental and substance use disorders with academia-industry partnerships.
Supports research advancing discovery and development of new treatments and devices for mental and substance use disorders.
Supports renewal applications for existing NINDS clinical trial cooperative agreements needing more time and resources to complete trials.
Supports early-stage drug development for Alzheimer's disease including pre-clinical and Phase I clinical testing of novel therapies.
